UNSPSC 51331501: Armodafinil or modafinil

This classification denotes a cns stimulant with the molecular formula C15H15NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V63XWA605I, chemically known as acetamide, 2-((diphenylmethyl)sulfinyl)- but generally known as armodafinil, which bears US NIH Compound Identifier 4236. European Medicines Agency schedules Armodafinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32249.

The term ARMODAFINIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53). Armodafinil or modafinil bears US NLM identifiers UMLS ID C0066677 and NCI Concept Code C26661. SMILES: S(=O)(C(C1CCCCC1)C1CCCCC1)CC(=O)N.

UNSPSC 51331501 Armodafinil or modafinil is a Commodity code that shows little relevant recent activity in state and local procurement. The single opportunity tagged to this code in the recent record—Seminole County, Florida's IFB for naloxone and drug deactivation systems—falls outside the pharmaceutical stimulant scope the code nominates. The mismatch suggests either a tagging error or the county's application of the code to broader pharmaceutical procurement, but the naloxone solicitation does not reflect the substance this code is designed to track.

No representative state and local opportunities for armodafinil or modafinil procurement appear in the recent record. Firms considering activity under this code should monitor state health departments, correctness agencies, and specialty pharmacy cooperative purchasing vehicles for cognitive or alertness-support procurements, but current visibility into this market segment through state and local channels remains minimal.